利用SPYTACs在阿尔茨海默病中高效降解淀粉样蛋白-β
Efficient amyloid-β degradation in Alzheimer’s disease using SPYTACs
生物技术与制药领域的最新动态
Efficient amyloid-β degradation in Alzheimer’s disease using SPYTACs
Genetically encoded fluorescent reporters to visualize α-synuclein pathology in live brain
Restoring circadian rhythms in the hypothalamic paraventricular nucleus reverses aging biomarkers and extends lifespan in male mice
Tenaya, Alnylam ink research collab to find gene targets for cardio drugs
Pressure builds as back-and-forth between uniQure and FDA intensifies
Alltrna undergoes third layoff round before entering clinic, cutting 35% of jobs
FDA approves J&J's multiple myeloma combo as second-line treatment
Helus Pharma's stock slides after psychedelic drug data face questions over dosing
New FDA bonus pilot to address 'workforce challenges'
Can a wealthy family change the course of a deadly brain disease?
Lonza Group AG to set up GCC in Hyderabad - The Hindu
Eli Lilly's new program aims to boost employer coverage of GLP-1s
Lilly targets employers in new bid to broaden access to obesity drugs
Tenaya wins support from Alnylam in cardio disease pact
Daiichi Sankyo pens pact with Germany's Gaia to sell digital therapeutic for high cholesterol
VC firm to open 30K-square-foot biotech incubator in Salt Lake City
BCI retinal implant medtech Science closes major $230M series C round
Brain’s hidden tau-clearing pathway uncovered
PepGen muscular dystrophy drug gets ‘surprise’ hold from FDA
Health AI dispatch from SF